Lovastatin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Lovastatin was the first commercially available statin and is a moderate-intensity agent derived from Aspergillus terreus fungus. It was the first drug to clearly demonstrate that lowering cholesterol reduces cardiovascular events.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Lovastatin was the first commercially available statin and is a moderate-intensity agent derived from Aspergillus terreus fungus. NutriStack rates the supporting evidence as strong. Common adult dosing is 10–80 mg daily with evening meal (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: lowers ldl cholesterol by 20–40%, proven reduction in first major coronary events (afcaps/texcaps trial), reduces triglycerides modestly. 10 sources indexed (1991–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inactive lactone prodrug that is hydrolyzed in vivo to the active beta-hydroxyacid form. Inhibits HMG-CoA reductase, the rate-limiting step in cholesterol biosynthesis. Metabolized by CYP3A4. Reduces hepatic cholesterol synthesis, upregulates LDL receptors, and increases LDL clearance.
Dosing & protocol.
Immediate-release lovastatin should be taken with the evening meal to increase bioavailability by ~50%; avoid grapefruit juice1
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
ModerateHMG-CoA reductase inhibition reduces mevalonate pathway flux, lowering endogenous CoQ10 synthesis alongside cholesterol synthesis.
Full safety detail.
Side effects
- Myalgia and muscle cramps
- Elevated liver transaminases
- Gastrointestinal disturbances (flatulence, dyspepsia)
- Headache
- Rhabdomyolysis (rare)
- Insomnia
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Randomized controlled trials
4- 1Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X SyndromePMIDMcKinney WS, Schmitt LM, De Stefano LA et al. · Journal of child and adolescent psychopharmacology · 2025
McKinney WS, Schmitt LM, De Stefano LA et al.. Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome. Journal of child and adolescent psychopharmacology. 2025
- 2A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's DiseasePMIDLin CH, Chang CH, Tai CH et al. · Movement disorders : official journal of the Movement Disorder Society · 2021
Lin CH, Chang CH, Tai CH et al.. A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society. 2021
- 3Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1PMIDPayne JM, Barton B, Ullrich NJ et al. · Neurology · 2016
Payne JM, Barton B, Ullrich NJ et al.. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 2016
- 4The interaction of diltiazem with lovastatin and pravastatinPMIDAzie NE, Brater DC, Becker PA et al. · Clinical pharmacology and therapeutics · 1998
Azie NE, Brater DC, Becker PA et al.. The interaction of diltiazem with lovastatin and pravastatin. Clinical pharmacology and therapeutics. 1998
Reviews & position papers
1- 5Interaction between fibre and lovastatinPMIDRichter WO, Jacob BG, Schwandt P · Lancet (London, England) · 1991
Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin. Lancet (London, England). 1991
Reference material
5- 6Downs JR et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels (AFCAPS/TexCAPS). JAMA. 1998.Source linkedPMID
- 7Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the 4S study. Lancet. 1994.Source linkedPMID
- 8Wang Z et al. Statins for the primary prevention of venous thromboembolism. Cochrane Database Syst Rev. 2024.Source linkedPMID
- 9Duong H, Bajaj T. Lovastatin. 2026Source linkedPMID
- 10Santa Lucia G, Snyder A, Lateef A et al.. Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial. JAMA dermatology. 2023Source linkedPMID
Common questions.
Quick answers about Lovastatin, drawn from the data on this page.
What is Lovastatin?
Lovastatin was the first commercially available statin and is a moderate-intensity agent derived from Aspergillus terreus fungus. It was the first drug to clearly demonstrate that lowering cholesterol reduces cardiovascular events.
What is Lovastatin used for?
Commonly cited benefits of Lovastatin include: Lowers LDL cholesterol by 20–40%; Proven reduction in first major coronary events (AFCAPS/TexCAPS trial); Reduces triglycerides modestly; Available as extended-release formulation. NutriStack rates the overall evidence as strong.
What is a typical dose of Lovastatin?
A typical adult dose of Lovastatin is 10–80 mg daily with evening meal (as prescribed by your physician). The commonly recommended form is Oral tablet, taken with the evening meal for immediate-release. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Lovastatin?
Reported side effects include myalgia and muscle cramps, elevated liver transaminases, gastrointestinal disturbances (flatulence, dyspepsia), headache, rhabdomyolysis (rare), insomnia. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Lovastatin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Lovastatin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.